Abbott advances two pulsed field ablation studies for AFib treatment

By Yahoo! Finance | Oct 11, 2024 at 12:41 PM EST

Abbott achieved key milestones in trials for their pulsed field ablation (PFA) technology, with positive results in VOLT-AF study for atrial fibrillation. The innovative VOLT PFA system offers improved catheter contact and stability, showing promise for AF treatment.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.